Skip to content

Single-center Prospective Study to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Ambulatory Blood Pressure Monitoring (ABPM)

Single-center Prospective Study to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Ambulatory Blood Pressure Monitoring (ABPM)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04548986
Acronym
OBPM_ABPM2020
Enrollment
63
Registered
2020-09-16
Start date
2020-08-06
Completion date
2022-12-23
Last updated
2023-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Hypertension

Brief summary

This study aims to assess the performances of optical blood pressure monitoring device, Aktiia.product in the context of cardiac rehabilitation program.

Interventions

DEVICEAktiia.product

The participants wear Aktiia.bracelet for the duration of the cardiac rehabilitation program. The device is initialized once per week.

Sponsors

Aktiia SA
CollaboratorINDUSTRY
Cyril Pellaton
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adult subjects (aged between 21 and 65) * Subjects fluent in written and spoken French * Subjects enrolled in a 12-weeks cardiac rehabilitation program * Subjects agreeing to participate * Subjects that have signed the informed consent form

Exclusion criteria

* Subjects with tachycardia (heart rate at rest \> 120bpm) * Subjects with atrial fibrillation * Subjects with severe heart failure (LVEF\<35%) * Subjects with severe renal dysfunctions (eGFR \< 30mL/min/1.73 m2) * Subjects with pheochromocytoma * Subjects with Raynaud's disease * Subjects with trembling and shivering * Subjects with interarm systolic difference \> 15 mmHg * Subjects with interarm diastolic difference \> 10 mmHg * Subjects with arm paralysis * Women in known pregnancy * Subjects with an arteriovenous fistula * Subjects with arm amputations * Subjects with the upper arm circumference \> 64 cm * Subjects with the wrist circumference \> 22 cm * Subjects with the exfoliative skin diseases * Subjects with lymphoedema

Design outcomes

Primary

MeasureTime frameDescription
Standard deviation of the error for heart rateup to 24 hoursThe standard deviation of the error between Reference and Aktiia.product for heart rate in bpm
Mean error for blood pressureup to 24 hoursThe mean error between the Reference and Aktiia.product for SYS and DIA in mmHg
Standard deviation of the error for blood pressureup to 24 hoursThe standard deviation of the error between Reference and Aktiia.product for SYS and DIA in mmHg
Mean absolute error for heart rateup to 24 hoursThe mean absolute error between the Reference (standard ambulatory blood pressure monitor) and Aktiia.product for heart rate in bpm
Mean error for heart rateup to 24 hoursThe mean error between the Reference and Aktiia.product for heart rate in bpm
Mean absolute error for blood pressureup to 24 hoursThe mean absolute error between the Reference (standard ambulatory blood pressure monitor) and Aktiia.product for systolic (SYS) and diastolic (DIA) blood pressure in mmHg

Secondary

MeasureTime frameDescription
Evaluation of patient's satisfaction for the two devices through a survey with multiple questionsup to 24 hours10-points likert scale survey, an agree-disagree scale with minimum 0 and maximum 10. Minimum value means strong disagreement, maximum value means strong agreement.
Assessment of the calibration stability of Aktiia OBPM algorithms12 weeksUse different calibration points going from 1 to 12 weeks
Assessment of systolic and diastolic blood pressure control during a 12 weeks cardiac rehabilitation program12 weekscomparison of blood pressure determinations taken at the beginning and at the end of the program in ambulatory settings
Evaluation of the impact of ABPM induced stress on BP readings using inferential statistics.1 weekAktiia values acquired during the first day (with ABPM) will be compared to values acquired during other days of the week and a t-test will be performed. The analysis will be repeated for night values.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026